Almac adds language-based pack unit for niche and orphan drugs
Almac says new late-stage customisation suite at its facility will cater for firms wishing to launch orphan and niche drugs in Europe.
Almac says new late-stage customisation suite at its facility will cater for firms wishing to launch orphan and niche drugs in Europe.
The EMA is to develop guidance on transfer of analytical methods to tackle GMP issues arising from globalisation and increased use of CMOs.
The Christie cancer centre in Manchester, UK, has opened a £35m (€41m) early phase clinical trial unit to help develop new treatments for a range of cancers.
Aluminium lakes and in-liner packaging can, in some cases, be used to control reactive components in excipients and therefore overcome drug product instability.
GlaxoSmithKline will sell its oral penicillin manufacturing facility in Tennessee, US, to Dr Reddy’s for an undisclosed sum, along with US rights to its Augmentin and Amoxin brands.
SGS Life Sciences will expand bioanalytical capacity at its facility in Poitiers, France in the latest stage of its effort to become the biggest biologics testing services firm by 2014.